Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MGC Pharmaceuticals' "numbers were very good" in Q4 2022

By: News Direct

--News Direct--

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief commercial officer Robert Clements speaks to Proactive's Thomas Warner about how the business performed during the fourth quarter of 2022. Clements says that the "numbers were very good" and reveals more details about how the business is changing as it heads into a new calendar year.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/mgc-pharmaceuticals-numbers-were-very-good-in-q4-2022-130248078

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.79
+3.64 (1.81%)
AAPL  264.35
+0.47 (0.18%)
AMD  200.12
-2.96 (-1.46%)
BAC  53.36
+0.62 (1.18%)
GOOG  303.94
+1.12 (0.37%)
META  643.22
+3.93 (0.61%)
MSFT  399.60
+2.74 (0.69%)
NVDA  187.98
+3.01 (1.63%)
ORCL  156.17
+2.20 (1.43%)
TSLA  411.32
+0.69 (0.17%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.